203 related articles for article (PubMed ID: 27879658)
1. The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation.
Miller BF; Sánchez-Vega F; Elnitski L
Biomolecules; 2016 Nov; 6(4):. PubMed ID: 27879658
[TBL] [Abstract][Full Text] [Related]
2. Pan-cancer analysis reveals presence of pronounced DNA methylation drift in CpG island methylator phenotype clusters.
Karpinski P; Pesz K; Sasiadek MM
Epigenomics; 2017 Nov; 9(11):1341-1352. PubMed ID: 28960094
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer stratification of solid human epithelial tumors and cancer cell lines reveals commonalities and tissue-specific features of the CpG island methylator phenotype.
Sánchez-Vega F; Gotea V; Margolin G; Elnitski L
Epigenetics Chromatin; 2015; 8():14. PubMed ID: 25960768
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis.
Yates J; Boeva V
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35134107
[TBL] [Abstract][Full Text] [Related]
5. Integrated analysis of genetic and epigenetic alterations reveals CpG island methylator phenotype associated with distinct clinical characters of lung adenocarcinoma.
Shinjo K; Okamoto Y; An B; Yokoyama T; Takeuchi I; Fujii M; Osada H; Usami N; Hasegawa Y; Ito H; Hida T; Fujimoto N; Kishimoto T; Sekido Y; Kondo Y
Carcinogenesis; 2012 Jul; 33(7):1277-85. PubMed ID: 22532250
[TBL] [Abstract][Full Text] [Related]
6. Biological significance of the CpG island methylator phenotype.
Suzuki H; Yamamoto E; Maruyama R; Niinuma T; Kai M
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):35-42. PubMed ID: 25016183
[TBL] [Abstract][Full Text] [Related]
7. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
Kusano M; Toyota M; Suzuki H; Akino K; Aoki F; Fujita M; Hosokawa M; Shinomura Y; Imai K; Tokino T
Cancer; 2006 Apr; 106(7):1467-79. PubMed ID: 16518809
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations in colorectal cancer: the CpG island methylator phenotype.
Bae JM; Kim JH; Kang GH
Histol Histopathol; 2013 May; 28(5):585-95. PubMed ID: 23341177
[TBL] [Abstract][Full Text] [Related]
9. CpG island methylator phenotype (CIMP) in cancer: causes and implications.
Teodoridis JM; Hardie C; Brown R
Cancer Lett; 2008 Sep; 268(2):177-86. PubMed ID: 18471961
[TBL] [Abstract][Full Text] [Related]
10. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
Karpinski P; Ramsey D; Grzebieniak Z; Sasiadek MM; Blin N
Mol Cancer Res; 2008 Apr; 6(4):585-91. PubMed ID: 18403637
[TBL] [Abstract][Full Text] [Related]
11. Integrative DNA methylation and gene expression analysis to assess the universality of the CpG island methylator phenotype.
Moarii M; Reyal F; Vert JP
Hum Genomics; 2015 Oct; 9():26. PubMed ID: 26463173
[TBL] [Abstract][Full Text] [Related]
12. Multilevel omic data clustering reveals variable contribution of methylator phenotype to integrative cancer subtypes.
Karpinski P; Patai AV; Hap W; Kielan W; Laczmanska I; Sasiadek MM
Epigenomics; 2018 Oct; 10(10):1289-1299. PubMed ID: 29896967
[TBL] [Abstract][Full Text] [Related]
13. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
14. 18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
Ogino S; Kawasaki T; Kirkner GJ; Ohnishi M; Fuchs CS
BMC Cancer; 2007 May; 7():72. PubMed ID: 17474983
[TBL] [Abstract][Full Text] [Related]
15. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
16. Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancers.
An B; Kondo Y; Okamoto Y; Shinjo K; Kanemitsu Y; Komori K; Hirai T; Sawaki A; Tajika M; Nakamura T; Yamao K; Yatabe Y; Fujii M; Murakami H; Osada H; Tani T; Matsuo K; Shen L; Issa JP; Sekido Y
Int J Cancer; 2010 Nov; 127(9):2095-105. PubMed ID: 20131317
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a CIMP-associated prognostic model for hepatocellular carcinoma.
Li G; Xu W; Zhang L; Liu T; Jin G; Song J; Wu J; Wang Y; Chen W; Zhang C; Chen X; Ding Z; Zhu P; Zhang B
EBioMedicine; 2019 Sep; 47():128-141. PubMed ID: 31492561
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype.
Toyota M; Ahuja N; Suzuki H; Itoh F; Ohe-Toyota M; Imai K; Baylin SB; Issa JP
Cancer Res; 1999 Nov; 59(21):5438-42. PubMed ID: 10554013
[TBL] [Abstract][Full Text] [Related]
19. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
Noushmehr H; Weisenberger DJ; Diefes K; Phillips HS; Pujara K; Berman BP; Pan F; Pelloski CE; Sulman EP; Bhat KP; Verhaak RG; Hoadley KA; Hayes DN; Perou CM; Schmidt HK; Ding L; Wilson RK; Van Den Berg D; Shen H; Bengtsson H; Neuvial P; Cope LM; Buckley J; Herman JG; Baylin SB; Laird PW; Aldape K;
Cancer Cell; 2010 May; 17(5):510-22. PubMed ID: 20399149
[TBL] [Abstract][Full Text] [Related]
20. The CpG island methylator phenotype: what's in a name?
Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
